March 22nd, 2022
2:00 PM to 4:30 PM
An estimated 1.1 million people living in private households in the UK (1.7% of the population) were experiencing self-reported “long COVID” (symptoms persisting for more than four weeks after the first suspected coronavirus (COVID-19) infection, that were not explained by something else) as of 5th September 2021; this is up from 970,000 (1.5%) as of 1st August 2021, reflecting increased COVID-19 infection rates in July 2021. See further information here.
Some people recovering from COVID-19 still experience symptoms such as fatigue, fever, and cognitive dysfunction for weeks (5% to 36% of people) or even months (5% to 15% of people) after their infection. This is commonly referred to as long COVID. Long COVID is potentially a serious Illness, with broad negative consequences for the individual suffering from it, as well as at the societal level. In addition, financial and employment consequences are arising and elevated levels of sickness absence and presenteeism are to be expected.
2.00 pm Welcome Professor Ewan Macdonald, OBE, University of Glasgow
2.05 pm Long Covid and return to work – a Research overview – Prof Godderis
2.35 pm Employer perspectives and the new CIPD resource on Long Covid– Rachel Suff and Jo Yarker; CIPD
3.00 pm Clinical Perspectives across the UK
- England – Dr Fauzia Begum
- Scotland – Prof Ewan Macdonald with Dr John Harden tbc
- Wales – Dr Richard Williams tbc
- NI – Dr Sarah Porter
3.50 pm Patient perspectives on variability of support – Lesley Macniven, Long Covid Employment Group
4.05 pm Discussion with Dr Clare Rayner; Dr David Strain tbc; Prof Ewan Macdonald; FOM tbc and CMOs for discussion/ comment
4:30 pm – Close
FREE to register.
After booking, you will then be sent the join link
HSE return to work evidence review:
Long COVID leaflet
The direct link to the PDF is